Compass Therapeutics, Inc. - Common Stock (NQ:CMPX)

0.9981 +0.0375 (+3.90%)

Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Compass Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >

3 Stocks Under $2 Insiders Are Buying ↗

May 11, 2022

US crude oil futures traded higher on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the...

Via Benzinga

51 Biggest Movers From Yesterday ↗

April 06, 2022

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 05, 2022

Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 141.5% to $5.46 during Tuesday's regular session. Trading volume for this security as of 13:30 EST is 114.7...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2022 ↗

March 15, 2022

Upgrades For Turquoise Hill Resources Ltd (NYSE:TRQ), BMO Capital upgraded the previous rating of Underperform to Market Perform. Turquoise Hill Resources earned $0.78 in the...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 07, 2022

Gainers Nuvectis Pharma (NASDAQ:NVCT) stock moved upwards by 132.3% to $7.55 during Monday's regular session. The current volume of 17.0 million shares is 2307.5% of...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 31, 2022

Gainers Calithera Biosciences (NASDAQ:CALA) shares moved upwards by 42.8% to $0.6 during Monday's regular session. As of 12:30 EST, Calithera Biosciences's stock...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

January 31, 2022

On Monday morning, 49 companies achieved new lows for the year. Points of Interest From Today's 52-Week Lows: The largest company by market cap to hit a new 52-...

Via Benzinga

FDA Gives Green Signal To Compass Therapeutics' Mid-Stage Biliary Tract Cancer Trial In US ↗

January 20, 2022

The FDA has signed off Compass Therapeutics Inc's (NASDAQ: CMPX) IND application for CTX-009 to initiate a global Phase 2 clinical trial for CTX-009 for...

Via Benzinga

Compass Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

January 07, 2022

From Compass Therapeutics, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022 ↗

January 19, 2022

Upgrades For Rocket Companies Inc (NYSE:RKT), JP Mo...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2021 ↗

December 22, 2021

Upgrades According to Loop Capital, the prior rating for Williams-Sonoma Inc (NYSE:

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 10, 2021

Gainers Quoin Pharmaceuticals (NASDAQ:

Via Benzinga

Compass Therapeutics to Present at the Piper Sandler 33rd Annual Healthcare Conference

November 22, 2021

From Compass Therapeutics, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2021 ↗

December 20, 2021

Upgrades According to Keefe, Bruyette & Woods, the prior rating for Old National Bancorp (NASDAQ:...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 19, 2021

Gainers CASI Pharmaceuticals (NASDAQ:CASI

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 17, 2021

Gainers Rani Therapeutics Hldgs (NASDAQ:RA...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021 ↗

December 15, 2021

Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE:

Via Benzinga

61 Biggest Movers From Yesterday ↗

December 02, 2021

Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) shares jumped 44.1% to close $4.61 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down...

Via Benzinga

Topics Intellectual Property

Compass Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update

November 12, 2021

From Compass Therapeutics, Inc.

Via Business Wire

3 Penny Stocks Insiders Are Buying ↗

November 09, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 09, 2021

Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the...

Via Benzinga

32 Stocks Moving in Tuesday's Pre-Market Session ↗

November 09, 2021

Gainers Dover Motorsports, Inc. (NYSE: DVD) rose 57% to $3.58 in pre-market trading. Luminar Technologies, Inc. (NASDAQ: LAZR) rose 54.2% to $26.98 in pre-market trading after...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 03, 2021

Gainers Glaukos (NYSE:GKOS) stock increased by 25.55% to $56.58 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.6 billion...

Via Benzinga

71 Biggest Movers From Yesterday ↗

November 03, 2021

Gainers Avis Budget Group, Inc. (NASDAQ: CAR) shares climbed 108.3% to close at $357.17 on Tuesday after the company reported better-than-expected Q3 adjusted EPS and sales...

Via Benzinga

Mid-Morning Market Update: Markets Edge Higher; Pfizer Boosts FY21 Outlook ↗

November 02, 2021

Following the market opening Tuesday, the Dow traded up 0.08% to 35,942.26 while the NASDAQ rose 0.18% to 15,624.19. The S&P also rose, gaining 0.24% to 4,624.80. The U.S. has...

Via Benzinga

Topics Stocks

Compass Therapeutics Announces Pricing of Approximately $125 Million Public Offering of Common Stock and Uplisting to Nasdaq Capital Market

November 01, 2021

From Compass Therapeutics, Inc.

Via Business Wire

Compass Therapeutics Announces Proposed Public Offering of Common Stock and Uplisting to Nasdaq Capital Market

November 01, 2021

From Compass Therapeutics, Inc.

Via Business Wire

Compass Reports the Advancement of CTX-009, a Bispecific Antibody, to Phase 2a Development in Patients with Biliary Tract Cancers (BTC), and the Clearance of a Key Clinical Hurdle

November 01, 2021

From Compass Therapeutics, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2021 ↗

October 20, 2021

Upgrades For Iridium Communications Inc (NASDAQ:IRD...

Via Benzinga

CTX-009 (ABL001/ES104) Clinical Data Presented Today at the New Drugs on the Horizon Plenary Session of the 2021 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

October 08, 2021

From Compass Therapeutics, Inc.

Via Business Wire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.